TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT01605734 · UNKNOWN

Trial details

NCT number: NCT01605734
Sponsor: Shandong Cancer Hospital and Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

PHENYTOIN/SORAFENIB [VA Drug Interaction]Carcinoma, Hepatocellular

Start date: 2012-07-01
Primary completion: 2013-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.